Status
Acquired by Janssen, Pharmaceutical Company Of Johnson & Johnson on June 28, 2012
Funding Received
$879.6 Thousand in 1 Round from 2 Investors
Headquarters:
Martinsried
Description:
Corimmun is a drug development company focused on therapeutics and diagnostics for heart and vascular diseases.
Categories:
Biotechnology
Website:
http://www.corimmun.com

Company Details

Update

Corimmun is a clinical drug developing company located in Martinsried near Munich, Germany, and is focused on novel therapeutics and diagnostics for heart and vascular diseases. Corimmun's activities and experiences comprise all steps from research to drug development and commercialization.

Funding Rounds (1) - $879.6k

Update

Investors (2)

Update

Offices/Locations (1)

Update
  • Office

    Lochhamer Str. 29; Rückgebäude

    Martinsried, D-82152

    DEU

Images (1)

Update
  • E63b3f6c81cb03edb5c172f2538e7d3f